Exogene

Etcembly

The company develops an artificial intelligence platform to discover and engineer T cell receptor immunotherapies for biotechnology and pharmaceutical organisations.

Neogene Therapeutics

This biotechnology company develops engineered T cell receptor therapies targeting neoantigens in solid cancers for patients with oncology needs.

Exomnis Biotech

This company develops engineered bacteria as delivery vehicles for cancer immunotherapies, serving pharmaceutical companies and clinical researchers.

ImmunoScape

This biotechnology company develops T-cell receptor immunotherapies and immune profiling platforms for pharmaceutical firms and academic researchers to treat solid tumours.

Toxometris.ai

This company provides an artificial intelligence platform for predicting chemical toxicity and drug properties for pharmaceutical and biotechnology researchers.

Eigen Therapeutics

The company develops AI-enabled priming therapies to enhance the effectiveness of targeted cancer treatments for healthcare providers and pharmaceutical patients.

Synteny Biotechnology

The company develops generative AI platforms to design programmable protein therapeutics and precision immunology treatments for biotechnology researchers and pharmaceutical developers.

DropPrint Genomics

This company develops single-cell genomics software and an immune cell database for pharmaceutical researchers and biotechnology firms to improve drug discovery processes.